Literature DB >> 2569708

Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.

X Zhang1, E Silva, D Gershenson, M C Hung.   

Abstract

There are two genes related to the v-erb B oncogene in the human genome. The c-erb B-1 gene encodes the epidermal growth factor receptor (EGF-r), and the c-erb B-2/neu gene encodes a receptor-like protein very similar to, but distinct from the EGF-r. Southern blot analysis of DNAs from 15 fresh human ovarian carcinomas showed that the c-erb B-2/neu gene was amplified in 3 tumors. The c-erb B-1/EGF-r gene was not amplified. However, in one case of adenocarcinoma of uterine endometrium, the c-erb B-1/EGF-r was found to be rearranged in the 5' region of this gene. The genomic structure of the rearranged c-erb B-1/EGF-r gene is similar to those found in the chicken v-erb B oncogene, which produces a truncated form of the EGF-r. The results suggest that amplification of the c-erb B-2/neu gene may play a role in the pathogenesis of ovarian carcinoma. Further, the human c-erb B-1/EGF-r gene in adenocarcinoma of uterine endometrium may be activated by a similar mechanism as that in the chicken v-erb B oncogene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569708

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Negative autoregulation of the neu gene is mediated by a novel enhancer.

Authors:  X Y Zhao; M C Hung
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  Identification and characterization of a novel enhancer for the rat neu promoter.

Authors:  D H Yan; M C Hung
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  Lack of HER-2 gene amplification and association with pathological and clinical characteristics of differentiated thyroid cancer.

Authors:  Wahid Mdah; Raneen Mzalbat; Peter Gilbey; Moshe Stein; Adi Sharabi; Jamal Zidan
Journal:  Mol Clin Oncol       Date:  2014-07-11

4.  Multiple cis- and trans-acting elements involved in regulation of the neu gene.

Authors:  T C Suen; M C Hung
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

5.  Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene.

Authors:  D H Yu; K Scorsone; M C Hung
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

6.  Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease.

Authors:  R Kremser; P Obrist; G Spizzo; H Erler; D Kendler; G Kemmler; G Mikuz; C Ensinger
Journal:  Virchows Arch       Date:  2003-03-08       Impact factor: 4.064

7.  Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.

Authors:  R J Hale; C H Buckley; H Fox; J Williams
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

Review 8.  The TRAIL to targeted therapy of breast cancer.

Authors:  Monzur Rahman; Janet G Pumphrey; Stanley Lipkowitz
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

9.  Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products.

Authors:  D Yu; T C Suen; D H Yan; L S Chang; M C Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  HER-2/neu and CD117 (c-kit) overexpression in patients with pesticide exposure and extensive stage small cell lung carcinoma (ESSCLC).

Authors:  Anil Potti; Apar Kishor Ganti; Sascha A Tuchman; Kaley Sholes; Eric Langness; Vijay Koka; Michael Koch
Journal:  J Carcinog       Date:  2005-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.